Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06346080

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,200 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.

Conditions

Interventions

TypeNameDescription
OTHERSurveyDiscrete choice survey

Timeline

Start date
2024-08-01
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2024-04-03
Last updated
2026-02-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06346080. Inclusion in this directory is not an endorsement.